SC
ELV icon

Saturna Capital’s Elevance Health ELV Stock Holding History

Saturna Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-209,939
Closed -$109M – 160
2024
Q3 		$109M Buy
209,939
+60
+0% +$32.1K 1.43% 28
2024
Q2 		$114M Hold
209,879
– – 1.51% 26
2024
Q1 		$109M Buy
209,879
+25,000
+14% +$12.4M 1.5% 28
2023
Q4 		$87.2M Sell
184,879
-365
-0.2% -$169K 1.36% 28
2023
Q3 		$80.7M Buy
185,244
+17,000
+10% +$7.71M 1.43% 28
2023
Q2 		$74.7M Buy
168,244
+29,110
+21% +$13.4M 1.29% 34
2023
Q1 		$64M Buy
139,134
+10
+0% +$4.76K 1.24% 34
2022
Q4 		$71.4M Sell
139,124
-9
-0% -$4.57K 1.54% 24
2022
Q3 		$63.2M Buy
+139,133
New +$66.6M 1.54% 25

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Saturna Capital's ELV Position: Q4 2024 in Review

Saturna Capital sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 209,939 shares — an estimated $109M sold.

Saturna Capital first reported a position in ELV in Q3 2022 and held it in 9 quarters. The position peaked at $114M in Q2 2024. 1,605 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Saturna Capital reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Saturna Capital sold 209,939 Elevance Health shares in Q4 2024, an estimated $109M.
  • Saturna Capital first reported a position in Elevance Health in Q3 2022 and held it in 9 quarters.
  • Saturna Capital's Elevance Health position peaked at $114M in Q2 2024.
  • 1,605 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Saturna Capital's 13F filing for Q4 2024, filed 7 Feb 2025.